CompletedNCT00989950
Official study titleOpen Label Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children 6-12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In SpringfieldADHDMedication studyAges 6–12
- Countries
- United States
- Sponsor
- Cox Health Systems
CompletedNCT04412499
Official study titleStudy of the Link Between Psychosocial Treatments and the Need of Pharmacological Treatments in Children With Attention Deficit Hyperactivity Disorder : a Retrospective Online Study for Parents
This study has finished and is no longer accepting participants.
In MontpellierADHDObservational studyAges 6–18
- Countries
- France
- Sponsor
- University Hospital, Montpellier
CompletedNCT01074294
Official study titleA Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adult Attention Deficit/ Hyperactivity Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockADHDMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT03719950
Official study titleMonocentric Study on the Quality of Life Among Adolescents With Attention Deficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
In Vandœuvre-lès-NancyADHDObservational studyAges 12–18
- Countries
- France
- Sponsor
- Centre Psychothérapique de Nancy
CompletedNCT00334880
What is this study about?This study evaluated the safety and effectiveness of NRP104 for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockADHDMedication studyAges 18–55
- Countries
- United States
- Sponsor
- New River Pharmaceuticals
CompletedNCT00783835
Official study titleA Multicenter Open Trial to Evaluate the Effectiveness and Quality of Life in Adults With Attention Deficit /Hyperactivity Disorder (ADHD) Treated With Long Acting Methylphenidate (CONCERTA)
This study has finished and is no longer accepting participants.
Multiple locations, including Belo HorizonteADHDMedication studyAges 18–65
- Countries
- Brazil
- Sponsor
- Janssen-Cilag Farmaceutica Ltda.
CompletedNCT00382616
Official study titleStudying the Effects of Phosphatidylserine Enriched With Omega-3 Fatty Acids on Symptoms of Attention-Deficit/Hyperactivity Disorder in Children
This study has finished and is no longer accepting participants.
In Tel AvivADHDMedication studyAges 8–13
- Countries
- Israel
- Sponsor
- Tel-Aviv Sourasky Medical Center
CompletedNCT04326543
Official study titleAssociation Between Temperament Dimensions and Awakening Salivary Cortisol Levels in Children and Adolescents With Attention Deficit Hyperactivity/Impulsivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In SassariADHDObservational studyAges 3–16
- Countries
- Italy
- Sponsor
- Università degli Studi di Sassari
CompletedNCT01040702
Official study titleThe Effect of Methylphenidate on Decision-making Ability of ADHD Adults
This study has finished and is no longer accepting participants.
In Hod HaSharonADHDMedication studyAges 21–50
- Countries
- Israel
- Sponsor
- Shalvata Mental Health Center
CompletedNCT01807299
Official study titleThe Effect of Physical Training and the Omega 3 Consumption on Attention Deficit
This study has finished and is no longer accepting participants.
In São PauloADHDPlacebo comparisonAges 7–14
- Countries
- Brazil
- Sponsor
- Federal University of São Paulo
CompletedNCT05150223
Official study titleThe Effects of Functional Power Training on Attention, Gross and Fine Motor Skills, Participation and Quality of Life in Children With Attention Deficit Hyperactivity Disorder
This study has finished and is no longer accepting participants.
In AntalyaADHDInterventional studyAges 6–12
- Countries
- Türkiye
- Sponsor
- Akdeniz University
CompletedNCT00418184
Official study titleA Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder
This study has finished and is no longer accepting participants.
In Petach-TiqvaADHDPlacebo comparisonAges 6–13
- Countries
- Israel
- Sponsor
- Enzymotec